ME
Mark Edgeworth
Non Executive Director at Vu.City
View Mark's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Non Executive Director
Present
Company Details
11-50 Employees
VU.CITY addresses the fundamental questions: if we build here; what will it look like; who will it affect; and how will it affect them? VU.CITY provides clarity for the built environment. Combining the power of data with the largest, most accurate 3D digital city models, VU.CITY helps us to understand the implications of change in the built environment. VU.CITY is currently live in of London, Manchester, Birmingham, Brighton and Belfast, with many more to come. By visualising proposed buildings in context, we speed up the planning process substantially. Decisions in relation to height, bulk, townscape, heritage and views can therefore be taken around the table, engaging with the design team, the client, consultants and local authority in real time. The data overlays ranging from listed buildings, transport access (PTAL), distances and duration of travel, pollution, pricing, opportunity areas and local frameworks are immediately available and visible within the 3 dimensional environment. Speeding up the decision making process will reduce the time and therefore cost related to the delivery of planning, and ultimately help bring schemes to market quicker, smarter and more affordably. WHO IS IT FOR? Architects Developers Planners Local authorities Transport Engineers Project Managers Contractors
Year Founded
2015
Social Media
LinkedinFacebookTwitter
Industry
Real Estate
HQ Location
The Whitehouse Belvedere Road London, SE1 8GA, GB
Keywords
Digital Twin3D Visualisation3D Visualization3D ModellingPropTechPlanTech3D City ModelsGenerative AIGenerative Designand Architecture Software
Discover More About Cleveland Clinic

Find verified contacts of Mark Edgeworth in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.